Faricimab & Asciminib Are First Products To Be Approved By All Access Consortium Regulators

 
• By Ian Schofield

A therapy for wet age-related macular degeneration and a new drug for leukemia have become the first two products to be approved by all countries involved in the international Access Consortium.

Four hands of businessmen connect gears to a puzzle on a background of sunset. Business concept idea, partnership, cooperation, teamwork, community, creative
International collaboration can streamline the regulatory machinery • Source: Shutterstock

More from International

More from Geography